Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Andelyn Biosciences Opens New CGT Manufacturing HQ | Contract Pharma

What are you searching for?

Sign in
Breaking News

Andelyn Biosciences Opens New CGT Manufacturing HQ

Facility includes 16 cGMP modular manufacturing suites with upstream, downstream, solution prep, and filling capabilities.

By: Anthony Vecchione

Andelyn Biosciences, a company that develops and manufactures cell and gene therapies, opened its new manufacturing headquarters, the Andelyn Corporate Center (ACC), in the Innovation District in Columbus, OH. The newly constructed state-of-the-art and regulatory-compliant facility complements Andelyn’s two existing facilities in Columbus.

With 180,000 square feet of office, laboratory, and manufacturing space, the ACC more than triples Andelyn’s footprint, ensuring the company will have the space and capabilities to meet the growing demand for its cell and gene therapy services.

Wade Macedone, CEO of Andelyn Biosciences, said, “The opening of the new Andelyn Corporate Center is a fitting tribute to our more than 20 years of leadership and innovation in the development and manufacture of viral vectors for gene therapy. The new facility includes 16 cGMP modular manufacturing suites with upstream, downstream, solution prep, and filling capabilities, along with quality control labs and warehouse and corporate headquarters space.

Macedone added, “This expansion significantly enhances the comprehensive Concept-to-Commercialization capabilities we provide to our biotechnology and pharmaceutical clients. We are proud of our record of success in this demanding field, with over 2,000 viral vector production runs and more than 450 cGMP batches delivered in support of more than 75 global gene therapy clinical trials.”



Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics